Scott D. Sandell - Significant Ownership

Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Scott D. Sandell.

Significant Ownership of Scott D. Sandell

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ACLX Arcellx, Inc. Common Stock $0.001 par value per share 5.51% $226M -$51.1M 3.06M -18.4% Scott D. Sandell Aug 12, 2025
VRNA Verona Pharma plc Ordinary Shares, nominal value 0.05 GBP 4.99% $1.89B 32.7M Scott D. Sandell Jan 16, 2025

Schedules 13D/G Reported by Scott D. Sandell:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.